During the past decade, BioSolutions Clinical Research Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 9 clinical trials were completed, i.e. on average, 34.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 9 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BioSolutions Clinical Research Center" #1 sponsor was "Flexion Therapeutics, Inc." with 4 trials, followed by "Unity Biotechnology, Inc." with 3 trials sponsored, "Centrexion Therapeutics" with 2 trials sponsored, "InGeneron, Inc." with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BioSolutions Clinical Research Center" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Pearl Pathways" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "BioSolutions Clinical Research Center" are "Osteoarthritis, Knee" (7 trials), "Osteoarthritis, Hip" (3 trials), "Osteoarthritis" (2 trials), "Osteoarthritis of the Shoulder" (2 trials) and "Adhesive Capsulitis" (1 trials). Many other conditions were trialed in "BioSolutions Clinical Research Center" in a lesser frequency.

Most popular intervention types in "BioSolutions Clinical Research Center" are "Drug" (23 trials), "Other" (7 trials), "Device" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Adipose Derived Regenerative Cells" (2 trials), "Corticosteroid" (2 trials), "FX006" (2 trials) and "FX006 32 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "BioSolutions Clinical Research Center" are 26 trials for "All" genders.

Currently, there are NaN active trials in "BioSolutions Clinical Research Center". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in BioSolutions Clinical Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in BioSolutions Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".